Tweetovi

Blokirali ste korisnika/cu @f_abbondanza

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @f_abbondanza

  1. Microsoft invested $40 million in "AI for Health", the latest to increase in and improve the development of , treatments and preventive measures for diseases

    Poništi
  2. "The program has returned medically actionable results to nearly 1,500 people who are at increased risk for potentially life-threatening conditions...”

    Poništi
  3. Poništi
  4. 2. velj
    Poništi
  5. 1. velj

    Interesting startup using multiplex quantitative PCR assays to develop a Thyroid cancer risk test!

    Poništi
  6. 1. velj

    A very nice overview of the current solutions...which one will you adopt? via

    Poništi
  7. 30. sij

    Nice to catch up with from at the ! I've recently interviewed his team, along with and , to write an article on and

    Poništi
  8. proslijedio/la je Tweet
    30. sij

    To infinity & beyond! ♾ , CEO, takes us on a journey of what comes after the project - looping & to advance the whole ecosystem!🚀

    Poništi
  9. proslijedio/la je Tweet
    30. sij

    CEO talks about the critical impact of patient focused research enabled by large and accessible cohorts.

    Poništi
  10. proslijedio/la je Tweet
    29. sij

    " has sequenced more in 2019 than in the previous 25 years" , Head of Scientific Computing @ Sanger, is giving a great overview of how we're accelerating through the initiative 🚀

    Poništi
  11. 28. sij

    Fantastic work on genome-wide rare variant analysis in multiple large-scale cohorts!

    Poništi
  12. 20. sij
    Poništi
  13. 15. sij
    Poništi
  14. 12. sij

    A quick review of 2019 from Nature ... the approved new drugs last year, mostly focused on . Average and median sales over the years show an interesting trend in the field...

    Poništi
  15. proslijedio/la je Tweet
    10. sij
    Poništi
  16. proslijedio/la je Tweet
    9. sij

    Our partnership democratises access to securely, empowering data-driven insights for customers and life sciences .

    Poništi
  17. proslijedio/la je Tweet
    9. sij

    We are absolutely thrilled to collaborate with to further our joint mission of advancing knowledge, making faster & more patient-centric, while helping to democratise access to the latest techniques.

    Poništi
  18. 7. sij

    For anyone interested in investing in biotech and pharma companies, this is a must-watch index!

    Poništi
  19. proslijedio/la je Tweet
    5. sij

    genetic testing companies need a , system that can provide the storage space to store & the computational resources to analyse the data

    Poništi
  20. proslijedio/la je Tweet
    20. pro 2019.

    & de-identification of are incredibly difficult to ensure - it is essential that researchers working with sensitive data employ highly optimised -preserving & techniques. Read on 👉

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·